title: ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical Sources.
abstract: This practice parameter is intended to guide appropriately trained and licensed physicians performing therapy with unsealed radiopharmaceutical sources. Such therapy requires close cooperation and communication between the physicians who are responsible for the clinical management of the patient and those who administer radiopharmaceutical therapy and manage the attendant side effects. Adherence to this practice parameter should help to maximize the efficacious use of these procedures, maintain safe conditions, and ensure compliance with applicable regulations. The goal of therapy with unsealed radiopharmaceutical sources is to provide either cure or effective palliation of disease while minimizing untoward side effects and complications.
authors.affiliation: From the *Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI; † Department of Radiation Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH; ‡Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA; §Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Spratt
authors.forename: Bassem I
authors.initials: BI
authors.lastname: Zaki
authors.forename: Benjamin L
authors.initials: BL
authors.lastname: Franc
authors.forename: Alan C
authors.initials: AC
authors.lastname: Hartford
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Osborne
mesh_terms: D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011878:Radiotherapy / Q000379:methods / Q000592:standards*
chemical_list: D019275:Radiopharmaceuticals